Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Brain Res. 2020 Dec 23;1752:147222. doi: 10.1016/j.brainres.2020.147222

Figure 7.

Figure 7.

Entinostat treatment attenuated brain lesion volume on day 3 post-ICH. Coronal brain sections were stained with Cresyl violet (A) and the lesion volume was estimated (B) as described in methods. Entinostat significantly reduced the lesion volume in comparison to control (ICH+ vehicle; n=3 and ICH+ Entinostat; n=4). (C) Entinostat treatment attenuated T2-weighted hemorrhagic lesion on day 3 post-ICH. Mice were subjected to T2-weighted MRI after ICH and hemorrhagic lesion volume was estimated, as detailed in methods. (D) Entinostat significantly reduced the hemorrhagic lesion volume after ICH in comparison to control (n= 4/group).